vs
STANDARD BIOTOOLS INC.（LAB）与SITE Centers Corp.（SITC）财务数据对比。点击上方公司名可切换其他公司
SITE Centers Corp.的季度营收约是STANDARD BIOTOOLS INC.的1.0倍（$20.5M vs $19.6M），SITE Centers Corp.净利率更高（657.2% vs -177.4%，领先834.6%），STANDARD BIOTOOLS INC.同比增速更快（-11.5% vs -41.4%），过去两年STANDARD BIOTOOLS INC.的营收复合增速更高（-12.2% vs -53.4%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
SITE Centers Corp.是一家公开上市的房地产投资信托企业，核心业务为购物中心投资。公司由伯特·沃尔斯坦于1965年创立，总部位于俄亥俄州比奇伍德。截至2019年底，该公司在美国持有170家购物中心的权益，可租面积达5700万平方英尺，同时还为Retail Value Inc.管理1320万平方英尺的资产，马萨诸塞州弗雷明翰的Shopper's World便是其全资持有的知名项目。
LAB vs SITC — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $20.5M |
| 净利润 | $-34.7M | $134.4M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | — |
| 净利率 | -177.4% | 657.2% |
| 营收同比 | -11.5% | -41.4% |
| 净利润同比 | -28.8% | 2409.0% |
| 每股收益（稀释后） | $-0.09 | $2.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $20.5M | ||
| Q3 25 | $19.6M | $27.1M | ||
| Q2 25 | $21.8M | $33.5M | ||
| Q1 25 | $40.8M | $42.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | $22.1M | $61.0M | ||
| Q2 24 | $22.5M | $87.5M | ||
| Q1 24 | $45.5M | $94.1M |
| Q4 25 | — | $134.4M | ||
| Q3 25 | $-34.7M | $-6.2M | ||
| Q2 25 | $-33.5M | $46.5M | ||
| Q1 25 | $-26.0M | $3.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-26.9M | $323.0M | ||
| Q2 24 | $-45.7M | $238.2M | ||
| Q1 24 | $-32.2M | $-23.6M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | -168.5% | -22.0% | ||
| Q2 25 | -118.1% | — | ||
| Q1 25 | -80.8% | 7.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | -120.9% | — | ||
| Q2 24 | -134.5% | — | ||
| Q1 24 | -132.2% | -34.8% |
| Q4 25 | — | 657.2% | ||
| Q3 25 | -177.4% | -22.7% | ||
| Q2 25 | -153.7% | 138.9% | ||
| Q1 25 | -63.8% | 7.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | -122.0% | 529.4% | ||
| Q2 24 | -203.3% | 272.2% | ||
| Q1 24 | -70.6% | -25.0% |
| Q4 25 | — | $2.55 | ||
| Q3 25 | $-0.09 | $-0.13 | ||
| Q2 25 | $-0.09 | $0.88 | ||
| Q1 25 | $-0.07 | $0.06 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.07 | $6.07 | ||
| Q2 24 | $-0.12 | $4.45 | ||
| Q1 24 | $-0.27 | $-0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $119.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $334.8M |
| 总资产 | $539.6M | $418.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $119.0M | ||
| Q3 25 | $129.4M | $128.2M | ||
| Q2 25 | $158.6M | $153.8M | ||
| Q1 25 | $150.9M | $58.2M | ||
| Q4 24 | — | $54.6M | ||
| Q3 24 | $210.6M | $1.1B | ||
| Q2 24 | $269.8M | $1.2B | ||
| Q1 24 | $287.1M | $551.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
| Q4 25 | — | $334.8M | ||
| Q3 25 | $399.7M | $308.3M | ||
| Q2 25 | $424.5M | $486.7M | ||
| Q1 25 | $454.6M | $519.6M | ||
| Q4 24 | — | $516.7M | ||
| Q3 24 | $489.3M | $2.7B | ||
| Q2 24 | $510.3M | $2.3B | ||
| Q1 24 | $577.3M | $2.1B |
| Q4 25 | — | $418.7M | ||
| Q3 25 | $539.6M | $654.0M | ||
| Q2 25 | $557.0M | $959.0M | ||
| Q1 25 | $579.6M | $929.8M | ||
| Q4 24 | — | $933.6M | ||
| Q3 24 | $681.5M | $3.1B | ||
| Q2 24 | $708.7M | $4.0B | ||
| Q1 24 | $777.7M | $3.9B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $19.6M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | — |
| 自由现金流率自由现金流/营收 | -118.1% | — |
| 资本支出强度资本支出/营收 | 4.5% | — |
| 现金转化率经营现金流/净利润 | — | 0.15× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $19.6M | ||
| Q3 25 | $-22.2M | $5.2M | ||
| Q2 25 | $-20.7M | $17.2M | ||
| Q1 25 | $-30.3M | $5.7M | ||
| Q4 24 | — | $112.0M | ||
| Q3 24 | $-27.9M | $36.8M | ||
| Q2 24 | $-39.0M | $66.5M | ||
| Q1 24 | $-62.5M | $40.0M |
| Q4 25 | — | — | ||
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | — | ||
| Q1 25 | $-35.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-30.1M | — | ||
| Q2 24 | $-41.0M | — | ||
| Q1 24 | $-63.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | — | ||
| Q1 25 | -86.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -136.4% | — | ||
| Q2 24 | -182.2% | — | ||
| Q1 24 | -138.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | 4.5% | — | ||
| Q2 25 | 8.7% | — | ||
| Q1 25 | 12.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.37× | ||
| Q1 25 | — | 1.86× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.28× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
SITC
暂无分部数据
